NociPharm

NociPharm Genetics is a Canadian biotechnology company specializing in the development of innovative wound care and pain management solutions. The company's flagship product, RescuDerm®, is a Health Canada-approved topical gel designed to treat skin trauma, including burns, cuts, and abrasions, by targeting the TRPV1 (nociceptor) receptor. Developed in collaboration with institutions like SickKids Hospital and Defense Research and Development Canada, RescuDerm utilizes a proprietary formulation of weak organic acids and EDTA to provide rapid pain relief, reduce inflammation, and offer potent antimicrobial and antibiofilm properties. NociPharm's technology focuses on desensitizing sensory neurons to accelerate the natural healing process while preventing infection. The company offers specialized formulas for both sunburn and heat burn treatment, providing a protective barrier that promotes tissue repair and minimizes scarring.